Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Aker Christopher Ray Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 393,750 options to buy @ $1.36, valued at $535.5k
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/26/2022 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 480,000 options to buy @ $0.26, valued at $124.8k
02/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2020 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Sold 876 shares @ $0.5211, valued at $456.5
08/17/2020 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Sold 872 shares @ $0.605, valued at $527.6
05/18/2020 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Sold 909 shares @ $0.6268, valued at $569.8
02/19/2020 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Sold 888 shares @ $0.8305, valued at $737.5
01/24/2020 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 210,000 options to buy @ $1.31, valued at $275.1k
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/15/2019 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 335,000 options to buy @ $0.64, valued at $214.4k
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2019 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Sold 899 shares @ $0.5506, valued at $495
07/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/16/2019 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 38,512 shares @ $0
Sold 6,950 shares @ $1.4095, valued at $9.8k
Granted 7,500 options to buy @ $0.95, valued at $7.1k
04/03/2019 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Sold 2,710 shares @ $0.9812, valued at $2.7k
02/06/2019 4 Aker Christopher Ray (Sr. VP & General Counsel) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 25,000 shares @ $0
Granted 25,000 options to buy @ $0.95, valued at $23.8k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy